Birmingham, West Midlands -- (SBWIRE) -- 12/13/2013 -- Value Penny Stocks issues special report on Polycom Inc (NASDAQ:PLCM), Fifth Street Finance Corp. (NASDAQ:FSC), Pan American Silver Corp. (USA) (NASDAQ:PAAS), Infinity Pharmaceuticals Inc. (NASDAQ:INFI).
Polycom Inc (NASDAQ:PLCM) opened its last trade at the price of $10.46. Its closing price was $10.39 after losing -0.67% for the day. The company traded with the total volume of 2.04 million shares, while its average trading volume remained 3.28 million shares. The beta of this stock stands at 1.05. Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration. The company offers video, voice, and content-management and content-sharing solutions, such as telepresence and conference room systems, home/work office solutions, applications for mobile devices, browser-based video collaboration, cloud-delivered services, and specialized healthcare video carts.
Has PLCM Found The Bottom and Ready To Move Up? Find Out Here
Fifth Street Finance Corp. (NASDAQ:FSC) percentage change plunged -1.10% to close at $9.01 with the total traded volume of 2.02 million shares, along with average volume of 1.93 million shares. The 52 week range of the stock remained $9.01 - $11.13, while its day lowest price was $9.01. The share price hit the day highest price of $9.14. Fifth Street Finance Corp. is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, and management buyouts in small and mid-sized companies.
Has FSC Found The Bottom And Ready To Gain Momentum? Find Out Here
Pan American Silver Corp. (USA) (NASDAQ:PAAS) traded on volume of 2.00 million shares in the last session against average volume of 2.12 million shares. The company started its trading session with the price of $10.50 and closed at $10.89 by scoring +1.02%. Pan American Silver Corp. engages in the exploration, development, and operation of silver producing properties and assets. It produces and sells silver, gold, copper, lead, and zinc.
Will PAAS Continue To Move Higher? Find Out Here
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) started its last trading session with the price of $13.29 and closed at $13.26 by scoring -0.38%. The stock traded with total volume of 2.01 million shares, while the average trading volume remained 1.16 million shares. The beta value of this stock stands at 0.53. Day range for the stock was $12.95 - $13.73. Infinity Pharmaceuticals, Inc., a drug discovery and development company, focuses on discovering, developing, and delivering medicines to patients for diseases with significant unmet need.
Will INFI Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)